False Scientifically refuted Certainty of evidence: high provisional C-ABX-12

Antibiotics should not be used as a treatment at all; nobody should take an antibiotic for any reason (not even after a tooth extraction); the body can cope on its own.

Safety note: Refusing, delaying or stopping antibiotics for serious bacterial infections can be fatal. This includes sepsis, meningitis, pneumonia, kidney infection, infected wounds and infections in people with diabetes. Children with signs of serious infection (for example fever with drowsiness, a non-blanching rash, fast or difficult breathing, or refusal to feed in babies) need urgent medical assessment; guidelines require antibiotics within 1 hour for suspected sepsis and bacterial meningitis. Seek medical care; do not leave hospital against medical advice during an infection. Decisions about antibiotics should be made with a physician. No individual medical advice is given here.
In short: This claim is false: antibiotics save lives in serious bacterial infections such as sepsis, meningitis and pneumonia, including in children, and every guideline reviewed requires prompt treatment; what is correct is only that many mild respiratory infections heal without antibiotics and that antibiotics are overused.
Conclusion: This claim is false and dangerous: antibiotics save lives in serious bacterial infections such as sepsis, meningitis and pneumonia, including in children; only their overuse for mild infections is a real problem.

Original statement

مش محتاج مضاد حيوي خالص انا لا اؤمن بالمضاد الحيوي كوسيله علاج نهائيا

verbatim according to source. Translation by the project; the Arabic wording is authoritative.

Translation

Antibiotics should not be used as a treatment at all; nobody should take an antibiotic for any reason (not even after a tooth extraction); the body can cope on its own.

Origin

Source status
Video transcript (own words)
Attribution
Elawady (machine transcript)
Video
Dr.D Clinics - Diaa Al Awady is live! الالتهاب الخلوي ❤️❤️❤️ (Open source)
Published
25 May 2025
Timestamp
0:48:05 (location in the original video’s automatic YouTube caption track; confirms where the words occur, not who speaks)
Attribution uncertainty
Archive transcript (YouTube CC or AI-generated); wording may contain transcription errors; no timestamps; 'published' is the date listed by the archive. Passage read in context.
Claimed mechanism

The body heals itself; antibiotics harm the microbiome.

Claimed health effect

Antibiotics unnecessary/harmful in all cases.

Population concerned

Everyone, including patients with infections

Geographic restriction by Elawady

none found

Diverging source versions

انا قلت ما حدش ياخد مضاد حيوي لاي سبب من الاسباب حتى كنت زمان بقول اللي هيزرع درس او هيشيل درس ياخد قرص واحد لا ما تاخدش كنت غلطان ما تاخدش خالص

Source status
Video transcript (own words)
Attribution
Elawady (machine transcript)
Video
Dr Diaa Al Awady د ضياء العوضي is live! الأكل وراء كل مشاكلك (Open source)
Published
20 July 2025
Timestamp
0:49:36 (location in the original video’s automatic YouTube caption track; confirms where the words occur, not who speaks)
Attribution uncertainty
Archive transcript (YouTube CC or AI-generated); wording may contain transcription errors; no timestamps; 'published' is the date listed by the archive. Passage read in context.

حتى لو سبق ل فيديوهات قديمه وقلت فيها خد قرص ولا قرصين ما تاخدش ما تاخدش جسمك قادر

Source status
Video transcript (own words)
Attribution
Elawady (machine transcript)
Video
Dr.D Clinics - Diaa Al Awady is live! الالتهاب الخلوي ❤️❤️❤️ (Open source)
Published
25 May 2025
Timestamp
0:48:32 (location in the original video’s automatic YouTube caption track; confirms where the words occur, not who speaks)
Attribution uncertainty
Archive transcript (YouTube CC or AI-generated); wording may contain transcription errors; no timestamps; 'published' is the date listed by the archive. Passage read in context.

سالته انه ياخد مضاد حيوي وادويه السكر قال لي ولا ياخد اي حاجه دي كلها موت

Source status
Video transcript (own words)
Attribution
Elawady (machine transcript)
Video
حاله من وعي وحصار الأصحاء لجهل الاطباء (Open source)
Published
25 March 2026
Timestamp
0:00:35 (location in the original video’s automatic YouTube caption track; confirms where the words occur, not who speaks)
Attribution uncertainty
Conversation with patients/relatives; Elawady recounts that he advised a hospitalised patient (blood glucose reported as 700) to take neither antibiotics nor diabetes drugs and to leave hospital on own responsibility.

بس ده مش معناه برض ان انا بقول مضاد الحوي مالوش لازمه

Source status
Video transcript (own words)
Attribution
Elawady (machine transcript)
Video
الجزء التالت من الندوة (Open source)
Published
2 March 2024
Timestamp
0:04:26 (location in the original video’s automatic YouTube caption track; confirms where the words occur, not who speaks)
Attribution uncertainty
Earlier (2024) seminar: a more moderate statement - 'this does not mean I say antibiotics are useless'. Recorded for fairness; later videos (2025) explicitly retract earlier moderate advice.
Source status
Archive editors
Attribution
Archive editors (eltayebat.com)
Origin
https://eltayebat.com/rule/antibiotic-overuse/
Attribution uncertainty
The archive itself takes a different position: 'Antibiotics save lives when used for confirmed bacterial infections ... The answer is not to abandon antibiotics; it is to reserve them for the infections that genuinely demand them.' This contradicts Elawady's transcript statements.

ياس يا جبله [موسيقى] ماحدش ياخد يا جماعه مضادات حيويه >> ماحدش ياخد مضادات حيويه يا جماعه >> والله العظيم خدعه ورب الكعبه خدعه يا جماعه ما حدش ياخد اعشاب ولا مضادات

Nobody should take antibiotics (or herbs); antibiotics are a deception.

Source status
Video transcript (own words)
Attribution
Elawady (machine transcript)
Video
Dr Diaa Al Awady د ضياء العوضي is live!صباح الخير اتباع العوضي (Open source)
Published
19 September 2025
Timestamp
not available (transcript has no timings)
Attribution uncertainty
Archive transcript (YouTube CC or AI-generated); no timestamps; 'published' is the date listed by the archive and may be the upload date. Live-stream transcripts can contain viewer comments read aloud; the quoted passage was checked in context to be spoken by Elawady.

Scientific assessment

False – The statement contradicts the robust evidence.

Certainty of evidence: high – Further research is very unlikely to change the assessment.

1. What was claimed?

Antibiotics should never be used.

2. What is demonstrably correct?

Many antibiotic prescriptions are unnecessary (A-ABX-19). For acute otitis media in children, antibiotics reduce pain only modestly (NNTB 20 at 2-3 days) and cause side effects (NNTH 14); serious complications were rare in both groups (I-ABX-09). In mild respiratory infections, delayed or no antibiotics gave similar outcomes for many symptoms with no difference in complications, and cut antibiotic use from 93% to 30% (I-ABX-101). So 'often not needed' is correct for some mild infections.

3. What is wrong or exaggerated?

A blanket refusal is contrary to strong evidence. In septic shock, each hour of delay in effective antimicrobial therapy was associated with an average 7.6% decrease in survival (I-ABX-08); in 49,331 sepsis patients, each hour of delay increased risk-adjusted mortality (OR 1.04 per hour) (I-ABX-07); a meta-analysis found lower mortality with antibiotics within 1 hour in septic shock (I-ABX-103). In randomised trials in young children with mild (fast-breathing) pneumonia, amoxicillin reduced treatment failure compared with no antibiotic (RR 0.84, 0.75-0.94; I-ABX-102). The Surviving Sepsis Campaign (I-ABX-104), NICE (sepsis in adults and children, meningitis, pneumonia) and WHO (I-ABX-105) all require prompt antibiotics for serious bacterial infections. The AMR burden studies (A-ABX-18, I-ABX-01) count deaths that occur because antibiotics no longer work, and the GBD authors estimate that better care including 'improved access to antibiotics' could avert 92.0 million deaths between 2025 and 2050 (I-ABX-01). Even the archive that hosts his material states that antibiotics 'save lives'.

4. What remains unclear?

None regarding the core point.

5. Which studies support it?

Only for the limited correct part (overuse; mild infections): A-ABX-19, I-ABX-09, I-ABX-101.

6. Which studies contradict it?

I-ABX-07, I-ABX-08, I-ABX-102 (children, RCTs), I-ABX-103, I-ABX-104 (Surviving Sepsis 2021), I-ABX-105 (WHO AWaRe), I-ABX-01, A-ABX-18; NICE NG253, NG254, NG240, NG250.

7. What applies to Germany and Europe?

Standard care in Germany/EU and the UK: antibiotics within 1 hour for high-risk sepsis in adults and children (NICE NG253/NG254) and for suspected bacterial meningitis (NICE NG240), within 4 hours for community-acquired pneumonia in hospital (NICE NG250); stewardship to avoid unnecessary use.

8. What is known about Egypt?

Same medical standard; overuse is common in Egyptian private primary care (antibiotics in 81.2% of infection consultations; I-ABX-131) and the regional AMR burden is high (I-ABX-02), which makes appropriate use more, not less, important.

9. What practical conclusion is appropriate?

Never refuse or stop antibiotics prescribed for a serious bacterial infection without medical advice. Unnecessary antibiotics should be avoided.

Assessment details

Rationale for certainty of evidence

Strong, consistent evidence that timely antibiotics reduce mortality in serious bacterial infections (sepsis/septic shock), plus the large burden of deaths from resistant (i.e. effectively untreatable) infections. It is correct that many minor infections (e.g. acute otitis media in high-income settings) often resolve without antibiotics.

Source quality

Machine transcripts of live talks; statement is categorical and repeated.

Regional transferability

Universal.

Individual exceptions

In mild, self-limiting infections antibiotics are often unnecessary; this is a case-by-case medical decision.

Regional scope of the claim
general (biological/medical)
Last reviewed
26 October 2026 provisional

Scientific evidence in detail

Scientifically refuted – High-quality evidence shows the opposite, or the claim contradicts well-established physiology.

Research question: In people with bacterial infections (including serious infections such as sepsis, pneumonia and meningitis, and in children), does avoiding antibiotics altogether lead to outcomes as good as appropriate antibiotic treatment?

Research question in detail (PICO)
Population
Children and adults with bacterial infections, from mild respiratory infections to sepsis, pneumonia and meningitis
Intervention or exposure
No antibiotics / refusal ('the body can cope')
Comparison
Guideline-based antibiotic treatment (immediate or delayed as appropriate)
Geographic scope
Universal biology; care standards similar in Europe and Egypt
Outcomes
  • Mortality
  • Treatment failure
  • Complications
  • Antibiotic use

Study results as reported by the authors. Our assessment follows below.

What speaks for the claim?

What speaks against the claim?

What does the overall evidence say?

Editorial assessment based on the studies above – not itself a study result.

Which position is better supported?

Refusing antibiotics in all cases is contrary to strong, consistent evidence and to every guideline found (WHO, NICE, Surviving Sepsis). The correct part is that many mild respiratory infections, such as colds and many ear and throat infections, resolve without antibiotics and that antibiotics are overused.

Why some studies weigh more

Guidelines and RCT/meta-analytic evidence on serious infections weigh most for the harm question; evidence on mild infections answers a different question (when antibiotics can be avoided safely).

Is a causal relationship established? Yes, established Antibiotics kill bacteria; untreated bacterial sepsis, meningitis and pneumonia have high mortality; RCTs show benefit even in mild childhood pneumonia, and delay in septic shock is associated with higher mortality.

Remaining uncertainty

Exact benefit per hour of delay in sepsis without shock; which children with mild pneumonia can safely go without antibiotics.

Justified conclusion

Blanket refusal of antibiotics is unsafe; stewardship (use when needed) is correct.

Why do studies seem to disagree?

No true conflict: trials showing that delayed or no antibiotics are safe concern mild, self-limiting respiratory infections in selected patients (I-ABX-101, I-ABX-09), whereas timing and RCT evidence in sepsis and pneumonia concerns infections where antibiotics prevent death or treatment failure (I-ABX-102-104, I-ABX-07, I-ABX-08). In children, an individual 1-hour antibiotic target was not independently significant in one New York cohort (Evans 2018, JAMA, PMID 30043064, abstract read), but completing the whole 1-hour bundle including antibiotics was associated with lower mortality; this concerns minutes-to-hours timing, not refusal.

Does this depend on the country?
General biological effects
Universal biology.
Eating habits
Not applicable (medicine use, not diet).
Legal rules
Antibiotics are prescription medicines in the EU; non-prescription dispensing is common in Egypt and other LMICs.
Actual monitoring data
Egypt: antibiotics in 81.2% of infection consultations in private primary care (I-ABX-131) - overuse is real there too, which argues for stewardship, not refusal.

A regional difference that changes the conclusion is not supported by robust data.

Statistical re-check
  • NNT – Jehan 2020: RD 2.3 points -> NNT 43 (27-111); pooled RR 0.84 (0.75-0.94) log-symmetric. recalculated
  • Per-hour odds – OR 1.04 per hour -> about 1.27 after 6 hours (multiplicative approximation). recalculated
Certainty of the overall evidence (GRADE, simplified)
Main outcome
Mortality/treatment failure without antibiotics in serious bacterial infections
Starting level
high (randomised trials)
Reasons for downgrading
  • indirectness for some timing data (comparisons of earlier vs later treatment, not none)
Reasons for upgrading
  • large effect in untreated serious infection
  • consistency across guidelines and designs
Result
high

Simplified assessment by a single reviewer, following the GRADE approach; not a formal GRADE panel. GRADE rates the body of evidence for one outcome, not individual studies.

Clinical guidelines and official statements checked
  • Surviving Sepsis Campaign (SCCM/ESICM): International guidelines for management of sepsis and septic shock 2021 (2021) · Original publication
    Administer antimicrobials immediately, ideally within 1 h, for possible septic shock or high likelihood of sepsis (strong recommendation); within 3 h for possible sepsis without shock if concern persists (weak).
  • NICE: NG253 Suspected sepsis in people aged 16 or over: recognition, assessment and early management (published 19 Nov 2025, updated 23 Sep 2026) (2026) · Original publication
    Give people aged 16 or over at high risk of severe illness or death from sepsis broad-spectrum intravenous antibiotics within 1 hour of calculating the NEWS2 score on initial assessment or deterioration; GPs in remote areas should be able to give antibiotics before transfer.
  • NICE: NG254 Suspected sepsis in under 16s: recognition, diagnosis and early management (published 19 Nov 2025) (2025) · Original publication
    For children and young people under 16 with any high-risk criterion: give a broad-spectrum antimicrobial without delay (within 1 hour of identifying high-risk criteria) and transfer immediately; babies under 3 months receive an additional antibiotic active against listeria (antibiotic chapter).
  • NICE: NG240 Meningitis (bacterial) and meningococcal disease: recognition, diagnosis and management (19 Mar 2024) (2024) · Original publication
    Transfer people with suspected bacterial meningitis or meningococcal disease to hospital as an emergency; give intravenous antibiotics as soon as bacterial meningitis is suspected, within 1 hour of arrival; give ceftriaxone or benzylpenicillin before arrival for strongly suspected meningococcal disease if this does not delay transfer.
  • NICE: NG250 Pneumonia: diagnosis and management (2 Sep 2025; replaces NG138) (2025) · Original publication
    Start antibiotic treatment as soon as possible after diagnosing community-acquired pneumonia, and within 4 hours of presentation to hospital.
  • WHO: The WHO AWaRe (Access, Watch, Reserve) antibiotic book (2022) · Original publication
    Inappropriate use and overuse of antibiotics drive AMR; the book gives evidence-based guidance on antibiotic choice, dose, route and duration for over 30 common infections in children and adults.
  • CDC: Core Elements of Outpatient Antibiotic Stewardship (2016) · Original publication could not be retrieved; content not used
Search strategy

Documented literature searches for this review (search strings in the original database syntax).

DatabaseDateSearchLooking forHitsIncluded
Europe PMC26 October 2026("delayed antibiotic" OR "no antibiotic" OR "antibiotic prescribing strategies") AND ("respiratory tract infection" OR "respiratory infections") AND (SRC:MED) AND (PUB_TYPE:"Systematic Review" OR JOURNAL:"Cochrane Database Syst Rev" OR TITLE:"meta-analysis")supporting evidence1621
Europe PMC26 October 2026("reduced antibiotic prescribing" OR "lower antibiotic prescribing") AND (pneumonia OR "peritonsillar abscess" OR complications) AND (safety) AND (primary care) AND SRC:MEDsupporting evidence121
Europe PMC26 October 2026TITLE:"Delayed antibiotic prescriptions for respiratory infections"supporting evidence1
Europe PMC26 October 2026TITLE:"Safety of reduced antibiotic prescribing for self limiting respiratory tract infections"supporting evidence1
Europe PMC26 October 2026DOI:"10.1002/14651858.CD004417.pub6"supporting evidence1
PubMed26 October 2026("Respiratory Tract Infections"[MeSH] AND "Anti-Bacterial Agents"[MeSH]) AND (placebo[tiab] OR "no antibiotic"[tiab]) AND (Cochrane Database Syst Rev[ta])supporting evidence101
Europe PMC26 October 2026(sepsis OR "septic shock") AND ("time to antibiotics" OR "antibiotic timing" OR "delay") AND (mortality) AND (PUB_TYPE:"Systematic Review" OR TITLE:"meta-analysis") AND PUB_YEAR:[2019 TO 2026]contradicting evidence1211
PubMed26 October 2026(sepsis[ti] OR "septic shock"[ti]) AND (antibiotic*[ti] OR antimicrobial*[ti]) AND (timing[ti] OR delay*[ti] OR "time to"[ti]) AND (meta-analysis[pt] OR systematic review[pt])contradicting evidence4
Europe PMC26 October 2026(pediatric OR paediatric OR children) AND sepsis AND ("time to antibiotic" OR "antibiotic delay" OR "hour" ) AND (mortality) AND (bundle OR antibiotics) AND PUB_YEAR:[2014 TO 2026] AND (JOURNAL:"JAMA" OR JOURNAL:"Crit Care Med" OR JOURNAL:"Pediatrics" OR JOURNAL:"Lancet*")contradicting evidence50
Europe PMC26 October 2026(bacterial meningitis) AND (antibiotic OR antimicrobial) AND (delay OR "door-to-antibiotic") AND (mortality OR "unfavourable outcome" OR "unfavorable outcome") AND (cohort OR "systematic review")contradicting evidence2923
Europe PMC26 October 2026TITLE:"New York Sepsis Care Mandate" AND TITLE:"Pediatric"contradicting evidence1
Europe PMC26 October 2026(placebo) AND (amoxicillin) AND ("fast breathing" OR "fast-breathing" OR "nonsevere pneumonia" OR "non-severe pneumonia") AND (children OR infants) AND (randomized OR randomised)both directions118
PubMed26 October 2026(pneumonia[ti]) AND (children[ti] OR child*[ti]) AND (placebo[ti] OR "no antibiotic"[ti] OR "without antibiotics"[ti])both directions30
Europe PMC26 October 2026(untreated OR "no antibiotic" OR "pre-antibiotic era" OR "preantibiotic era") AND (pneumococcal bacteremia OR "bacterial meningitis" OR "pneumococcal pneumonia") AND (mortality OR "case fatality")contradicting evidence14310
Europe PMC26 October 2026TITLE:"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021"guidelines5
Web (curl, who.int)26 October 2026https://www.who.int/publications/i/item/9789240062382guidelines1
Web (curl, nice.org.uk)26 October 2026https://www.nice.org.uk/guidance/ng253/chapter/Managing-suspected-sepsis ; https://www.nice.org.uk/guidance/ng254/chapter/Managing-suspected-sepsis ; https://www.nice.org.uk/guidance/ng240/chapter/Recommendations ; https://www.nice.org.uk/guidance/ng250/chapter/Recommendationsguidelines4

Open questions

Egyptian data on outcomes of patients who refuse antibiotics.

How deeply was this checked?

11 linked studies: 4 checked in full text (2 of them with a structured risk-of-bias assessment), 7 on the basis of the abstract, 0 bibliographically only. No formal assessment with two independent reviewers and no independent human expert review has taken place yet.

Last scientific review: 26 October 2026

History of the verdict
  1. 25 October 2026 · Phase 1 · Initial assessment: False (high)
  2. 26 October 2026 · Phase 4 (systematic evidence review) · Re-examined with extended evidence; verdict unchanged: False (high)
    New guidelines (NICE 2024-2026, WHO) and a 2026 meta-analysis of RCTs in children confirm the verdict; Cochrane evidence on mild infections confirms the limited correct part. No change needed; bottom line made explicit and safety note sharpened.
    New sources: I-ABX-101 I-ABX-102 I-ABX-103 I-ABX-104 I-ABX-105

In plain language

Dr Elawady said that nobody should take antibiotics for any reason and that the body can cope by itself. This is wrong and dangerous. In severe infections like sepsis, every hour of delay in antibiotic treatment increases the risk of death. It is true that many minor infections, like many ear infections in children, often heal without antibiotics, and that antibiotics are overused. The correct approach is to use antibiotics when they are needed, not never.

Studies on this claim

Studies supporting the claim (2)

  • Unnecessary antibiotic prescriptions in the US

    Fleming-Dutra KE et al.. JAMA 2016 · PMID 27139059 · DOI 10.1001/jama.2016.4151
    Cross-sectional studycited by the Tayebat archiveabstract checked★ key study

    About 30% of outpatient antibiotic prescriptions were judged unnecessary.

    Does the study support the specific claim? Yes · Methodological quality: high · Certainty of evidence: see overall assessment of the claim

    Original publication · Scientific details

    Study explained simply
    What did the researchers want to find out?

    Estimate inappropriate use.

    How was the study done?

    Survey analysis.

    How many people, animals or samples were studied?

    184,032 visits.

    What was actually found?

    30% inappropriate.

    How large was the observed effect?

    506 vs 353/1000.

    What do the results mean in everyday life?

    Overuse is common.

    What are the study's limitations?

    Estimated appropriateness.

    What does it say about Elawady's specific claim?

    Supports.

    Do the results apply to Germany and Europe?

    Low.

    What can explicitly not be concluded from this study?

    That antibiotics are never needed.

    Scientific details →

  • Antibiotics for children's ear infections (Cochrane 2023)

    Venekamp RP et al.. Cochrane Database Syst Rev 2023 · PMID 37965923 · DOI 10.1002/14651858.CD000219.pub5
    Systematic reviewindependent cross-checkabstract checked★ key study

    Antibiotics helped only a little with pain and caused side effects; serious complications were rare either way.

    Does the study support the specific claim? Partly · Methodological quality: high · Certainty of evidence: see overall assessment of the claim

    Original publication · Scientific details

    Study explained simply
    What did the researchers want to find out?

    Assess antibiotics in AOM.

    How was the study done?

    Cochrane review.

    How many people, animals or samples were studied?

    13 RCTs.

    What was actually found?

    Small benefit, some harm.

    How large was the observed effect?

    NNTB 20, NNTH 14.

    What do the results mean in everyday life?

    Many ear infections heal alone.

    What are the study's limitations?

    High-income only.

    What does it say about Elawady's specific claim?

    Supports 'often unnecessary', not 'never'.

    Do the results apply to Germany and Europe?

    High.

    What can explicitly not be concluded from this study?

    Serious infections.

    Scientific details →

Studies contradicting or limiting the claim (8)

  • Faster antibiotics in sepsis save lives

    Seymour CW et al.. N Engl J Med 2017 · PMID 28528569 · DOI 10.1056/NEJMoa1703058
    Cohort studyindependent cross-checkfull text, structured risk-of-bias assessment★ key study

    Each hour of delay in antibiotics was linked to about 4% higher odds of death.

    Does the study support the specific claim? No · Methodological quality: high · Certainty of evidence: see overall assessment of the claim

    Original publication · Scientific details

    Study explained simply
    What did the researchers want to find out?

    Assess timing.

    How was the study done?

    Cohort.

    How many people, animals or samples were studied?

    49,331 sepsis patients in 149 New York hospitals (2014-2016).

    What was actually found?

    Each hour of delay to antibiotics was linked to 4% higher odds of dying in hospital; delay from 1 to 6 hours to complete the bundle meant about 3 percentage points more deaths. Faster IV fluids showed no clear effect.

    How large was the observed effect?

    OR 1.04 per hour.

    What do the results mean in everyday life?

    Antibiotics are vital in sepsis.

    What are the study's limitations?

    Observational; antibiotic appropriateness unknown; one US state.

    What does it say about Elawady's specific claim?

    Contradicts 'never antibiotics'.

    Do the results apply to Germany and Europe?

    High.

    What can explicitly not be concluded from this study?

    Exact causal size of benefit per hour; applies to sepsis, not to minor infections.

    Scientific details →

  • Antibiotic timing in septic shock

    Kumar A et al.. Crit Care Med 2006 · PMID 16625125 · DOI 10.1097/01.CCM.0000217961.75225.E9
    Cohort studyindependent cross-checkabstract checked

    Each hour of delay reduced survival by about 7.6% on average.

    Does the study support the specific claim? No · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim

    Original publication · Scientific details

    Study explained simply
    What did the researchers want to find out?

    Assess delay.

    How was the study done?

    Cohort.

    How many people, animals or samples were studied?

    2154 patients.

    What was actually found?

    Delay worsens survival.

    How large was the observed effect?

    -7.6% per hour.

    What do the results mean in everyday life?

    Antibiotics are life-saving here.

    What are the study's limitations?

    Retrospective.

    What does it say about Elawady's specific claim?

    Contradicts claim.

    Do the results apply to Germany and Europe?

    High.

    Scientific details →

  • Antibiotic resistance deaths 1990-2050

    GBD 2021 Antimicrobial Resistance Collaborators. Lancet 2024 · PMID 39299261 · DOI 10.1016/S0140-6736(24)01867-1
    Risk assessmentindependent cross-checkfull text, structured risk-of-bias assessment★ key study

    About 1.14 million deaths were caused by resistance in 2021; better care and access to antibiotics could prevent tens of millions of deaths.

    Does the study support the specific claim? Partly · Methodological quality: high · Certainty of evidence: see overall assessment of the claim

    Original publication · Scientific details

    Study explained simply
    What did the researchers want to find out?

    Track AMR burden.

    How was the study done?

    GBD modelling.

    How many people, animals or samples were studied?

    520 million records.

    What was actually found?

    2021: 1.14 million deaths caused by resistance and 4.71 million deaths with a resistant infection; deaths in children under 5 fell by more than half since 1990, but rose by over 80% in people 70 and older.

    How large was the observed effect?

    1.91 M forecast for 2050.

    What do the results mean in everyday life?

    Resistance is rising; access to the right antibiotics matters.

    What are the study's limitations?

    Model estimates; little data in many poorer countries; forecasts depend on assumptions.

    What does it say about Elawady's specific claim?

    Supports burden; contradicts refusing antibiotics.

    Do the results apply to Germany and Europe?

    High.

    What can explicitly not be concluded from this study?

    Exact counts.

    Scientific details →

  • Global deaths from antibiotic resistance (2019)

    Antimicrobial Resistance Collaborators. Lancet 2022 · PMID 35065702 · DOI 10.1016/S0140-6736(21)02724-0
    Risk assessmentcited by the Tayebat archivefull text checked★ key study

    About 1.27 million deaths were directly caused by resistant bacteria in 2019.

    Does the study support the specific claim? Yes · Methodological quality: high · Certainty of evidence: see overall assessment of the claim

    Original publication · Scientific details

    Study explained simply
    What did the researchers want to find out?

    Estimate AMR burden.

    How was the study done?

    Global modelling.

    How many people, animals or samples were studied?

    471 million records.

    What was actually found?

    1.27 M attributable, 4.95 M associated deaths.

    How large was the observed effect?

    Regional rates 6.5-27.3/100,000.

    What do the results mean in everyday life?

    Resistance is a leading killer.

    What are the study's limitations?

    Model estimates.

    What does it say about Elawady's specific claim?

    Supports burden claim; not 'combined'.

    Do the results apply to Germany and Europe?

    High.

    What can explicitly not be concluded from this study?

    Exact counts.

    Scientific details →

  • Antibiotics help children with pneumonia

    Gadapani Pathak B et al.. J Glob Health 2026 · PMID 42725565 · DOI 10.7189/jogh.16.04209
    Meta-analysisindependent cross-checkfull text checked★ key study

    In randomised trials of young children with mild pneumonia, amoxicillin reduced treatment failure compared with no antibiotic.

    Children: amoxicillin vs no antibiotic RR 0.84 for treatment failure

    Does the study support the specific claim? No · Methodological quality: high · Certainty of evidence: see overall assessment of the claim

    Original publication · Scientific details

    Study explained simply
    What did the researchers want to find out?

    Test whether amoxicillin helps young children with mild pneumonia

    How was the study done?

    Meta-analysis of 4 randomised trials

    How many people, animals or samples were studied?

    7699 children aged 2-59 months

    What was actually found?

    Fewer treatment failures with amoxicillin

    How large was the observed effect?

    RR 0.84 (0.75-0.94); NNT about 43 in the largest trial

    What do the results mean in everyday life?

    Children with pneumonia should be assessed and treated by health workers; antibiotics reduce failures

    What are the study's limitations?

    Mostly mild cases in low-resource countries; one trial at high risk of bias

    What does it say about Elawady's specific claim?

    Contradicts the advice that no child should receive antibiotics

    Do the results apply to Germany and Europe?

    Moderate

    What can explicitly not be concluded from this study?

    Effects in severe pneumonia (no placebo trials exist because withholding treatment would be unsafe)

    Scientific details →

  • In sepsis, antibiotics given early save lives

    Ku NS et al.. Korean J Intern Med 2025 · PMID 40859809 · DOI 10.3904/kjim.2025.037
    Meta-analysisindependent cross-checkabstract checked★ key study

    Patients with septic shock who received antibiotics within 1 hour died less often than those treated later.

    Delay of antibiotics in septic shock associated with higher mortality

    Does the study support the specific claim? No · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim

    Original publication · Scientific details

    Study explained simply
    What did the researchers want to find out?

    Check whether antibiotic timing affects sepsis deaths

    How was the study done?

    Meta-analysis of 13 observational studies

    How many people, animals or samples were studied?

    79,246 patients

    What was actually found?

    Earlier antibiotics linked to lower mortality, clearly in septic shock

    How large was the observed effect?

    Not given numerically in abstract

    What do the results mean in everyday life?

    Sepsis is an emergency; antibiotics should not be delayed or refused

    What are the study's limitations?

    Observational data

    What does it say about Elawady's specific claim?

    Contradicts the claim

    Do the results apply to Germany and Europe?

    High

    What can explicitly not be concluded from this study?

    Exact benefit per hour in sepsis without shock

    Scientific details →

  • International sepsis guideline: give antibiotics immediately

    Evans L et al.. Intensive Care Med 2021 · PMID 34599691 · DOI 10.1007/s00134-021-06506-y
    Guideline / position statementindependent cross-checkabstract checked★ key study

    Experts recommend antibiotics within 1 hour for possible septic shock.

    Strong recommendation: antimicrobials immediately, ideally within 1 h, in possible septic shock

    Does the study support the specific claim? No · Methodological quality: high · Certainty of evidence: see overall assessment of the claim

    Original publication · Scientific details

    Study explained simply
    What did the researchers want to find out?

    Set standards for sepsis care

    How was the study done?

    Guideline with graded evidence

    How many people, animals or samples were studied?

    Not applicable

    What was actually found?

    Antibiotics within 1 hour for septic shock

    How large was the observed effect?

    Strong recommendation

    What do the results mean in everyday life?

    Sepsis needs emergency antibiotics

    What are the study's limitations?

    Timing evidence is of low quality

    What does it say about Elawady's specific claim?

    Contradicts refusing antibiotics

    Do the results apply to Germany and Europe?

    High

    What can explicitly not be concluded from this study?

    Exact minute-by-minute benefit

    Scientific details →

  • WHO: use the right antibiotic when needed, avoid overuse

    World Health Organization. WHO publication 2022
    Guideline / position statementindependent cross-checkabstract checked

    WHO gives antibiotic treatment guidance for over 30 common infections and warns against overuse.

    WHO treatment guidance for common infections plus stewardship against overuse

    Does the study support the specific claim? No · Methodological quality: high · Certainty of evidence: see overall assessment of the claim

    Original publication · Scientific details

    Study explained simply
    What did the researchers want to find out?

    Guide antibiotic choice worldwide

    How was the study done?

    WHO guidance book

    How many people, animals or samples were studied?

    Not applicable

    What was actually found?

    Treat common infections appropriately; avoid overuse

    How large was the observed effect?

    Not applicable

    What do the results mean in everyday life?

    Antibiotics are needed for many infections, but not for every illness

    What are the study's limitations?

    Only the web page was read

    What does it say about Elawady's specific claim?

    Contradicts refusing all antibiotics; agrees overuse is harmful

    Do the results apply to Germany and Europe?

    High

    What can explicitly not be concluded from this study?

    Exact recommendations for each infection (book not read)

    Scientific details →

Studies with mixed or unclear results (1)

  • Many mild chest, ear and throat infections can be managed without immediate antibiotics

    Spurling GK et al.. Cochrane Database Syst Rev 2023 · PMID 37791590 · DOI 10.1002/14651858.CD004417.pub6
    Systematic reviewindependent cross-checkabstract checked★ key study

    Delaying or not giving antibiotics for mild respiratory infections cut antibiotic use sharply with similar recovery and no difference in complications.

    Supports 'often not needed' for mild respiratory infections; not applicable to serious bacterial infections

    Does the study support the specific claim? Partly · Methodological quality: high · Certainty of evidence: see overall assessment of the claim

    Original publication · Scientific details

    Study explained simply
    What did the researchers want to find out?

    Compare immediate, delayed and no antibiotics for respiratory infections

    How was the study done?

    Cochrane review of 12 randomised trials

    How many people, animals or samples were studied?

    3968 children and adults

    What was actually found?

    Similar outcomes for many symptoms; much less antibiotic use with delay

    How large was the observed effect?

    Antibiotic use 30% vs 93% (delayed vs immediate)

    What do the results mean in everyday life?

    For mild coughs, colds and sore throats, waiting is often safe when a doctor judges it so

    What are the study's limitations?

    Mild infections only; rare complications poorly measured

    What does it say about Elawady's specific claim?

    Supports only the 'overuse' part of the claim, not 'never take antibiotics'

    Do the results apply to Germany and Europe?

    High

    What can explicitly not be concluded from this study?

    Whether serious bacterial infections can be left untreated (they were not studied)

    Scientific details →

Regional context

Germany / EU

Standard care in Germany/EU and the UK: antibiotics within 1 hour for high-risk sepsis in adults and children (NICE NG253/NG254) and for suspected bacterial meningitis (NICE NG240), within 4 hours for community-acquired pneumonia in hospital (NICE NG250); stewardship to avoid unnecessary use.

Egypt

Same medical standard; overuse is common in Egyptian private primary care (antibiotics in 81.2% of infection consultations; I-ABX-131) and the regional AMR burden is high (I-ABX-02), which makes appropriate use more, not less, important.

What applies in my country?

General scientific assessment

False This claim is false and dangerous: antibiotics save lives in serious bacterial infections such as sepsis, meningitis and pneumonia, including in children; only their overuse for mild infections is a real problem.

This statement concerns biological or medical relationships. The scientific assessment above applies regardless of the country; country-specific food data do not change it.

References

  1. Prevalence of Inappropriate Antibiotic Prescriptions Among US Ambulatory Care Visits, 2010-2011.. Fleming-Dutra KE et al.. JAMA 2016 · PMID 27139059 · DOI 10.1001/jama.2016.4151
  2. Antibiotics for acute otitis media in children.. Venekamp RP et al.. Cochrane Database Syst Rev 2023 · PMID 37965923 · DOI 10.1002/14651858.CD000219.pub5
  3. Time to Treatment and Mortality during Mandated Emergency Care for Sepsis.. Seymour CW et al.. N Engl J Med 2017 · PMID 28528569 · DOI 10.1056/NEJMoa1703058
  4. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock.. Kumar A et al.. Crit Care Med 2006 · PMID 16625125 · DOI 10.1097/01.CCM.0000217961.75225.E9
  5. Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050.. GBD 2021 Antimicrobial Resistance Collaborators. Lancet 2024 · PMID 39299261 · DOI 10.1016/S0140-6736(24)01867-1
  6. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.. Antimicrobial Resistance Collaborators. Lancet 2022 · PMID 35065702 · DOI 10.1016/S0140-6736(21)02724-0
  7. Oral amoxicillin for management of fast breathing or chest indrawing pneumonia without danger signs in children aged 2-59 months: a systematic review and meta-analysis.. Gadapani Pathak B et al.. J Glob Health 2026 · PMID 42725565 · DOI 10.7189/jogh.16.04209
  8. Appropriate timing of antibiotic initiation in patients with sepsis or septic shock: a systematic review and meta-analysis.. Ku NS et al.. Korean J Intern Med 2025 · PMID 40859809 · DOI 10.3904/kjim.2025.037
  9. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021.. Evans L et al.. Intensive Care Med 2021 · PMID 34599691 · DOI 10.1007/s00134-021-06506-y
  10. The WHO AWaRe (Access, Watch, Reserve) antibiotic book.. World Health Organization. WHO publication 2022
  11. Immediate versus delayed versus no antibiotics for respiratory infections.. Spurling GK et al.. Cochrane Database Syst Rev 2023 · PMID 37791590 · DOI 10.1002/14651858.CD004417.pub6

← Back to overview